After c-Met activation, its downstream pathways including mitogen-activated protein kinase (MAPK), extracellular signal-related kinase (ERK), and phosphatidylinositol 3-kinase (PI3K) are activated, which is conducive to tumor cells invasion and chemotherapy resistance (48, 49). Here, MET is linked to neoplasm.